文献速递肿瘤 PET/CT核素与放射性配体治疗

巨细胞动脉炎腹部罕见与常见部位的18F-FDG PET/CT诊断及随访

Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本文报道一例61岁女性巨细胞动脉炎的18F-FDG PET/CT表现,显示主动脉及大动脉受累,主动脉各分支均有摄取,腹部表现显著且少见。经包括静脉托珠单抗在内的治疗方案优化并随访2年,复查18F-FDG PET/CT评估为完全代谢缓解。

要点

  • 18F-FDG PET/CT可用于大血管炎的诊断、活动性监测及损伤进展评估。
  • 巨细胞动脉炎可累及主动脉各分支,腹部摄取可显著且不常见。
  • 经治疗优化后可用18F-FDG PET/CT评估代谢缓解。

核心结论

  • 巨细胞动脉炎可表现为主动脉及大动脉受累并伴主动脉各分支摄取,腹部可有显著且少见的摄取。
  • 经2年治疗优化(含静脉托珠单抗)后,18F-FDG PET/CT评估为完全代谢缓解。

研究设计与样本

  • 个案报道:1例61岁女性巨细胞动脉炎患者,采用18F-FDG PET/CT诊断并随访。

主要发现

  • 18F-FDG PET/CT显示常见巨细胞动脉炎模式(主动脉和大动脉)及主动脉所有分支摄取,腹部摄取显著且不常见。
  • 治疗优化2年(包括静脉托珠单抗)并用18F-FDG PET/CT监测,评估为完全代谢缓解。

临床怎么用

  • 对大血管炎疑似病例可用18F-FDG PET/CT辅助诊断并监测疾病活动性,包括接受白细胞介素6受体抑制剂治疗者。
  • 治疗过程中可用18F-FDG PET/CT评估损伤进展及代谢缓解。

局限性

  • 本文为单例个案报道,结论不能外推至所有巨细胞动脉炎患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Giant cell arteritis is not an uncommon disease, and its extension is furthermore finely assessed with new-generation PET/CT system. 18F-FDG PET/CT is increasingly used in case of large-vessel vasculitis for optimal diagnosis, activity monitoring (even when treated with interleukin 6 receptor inhibitor), and evaluation damage progression. We reported the case of a 61-year-old woman with common giant cell arteritis pattern on 18F-FDG PET/CT (aorta and large arteries) and uptakes in all aorta branches, mainly impressive and uncommon in the abdomen. After 2 years of therapeutic optimization including IV tocilizumab and monitoring with 18F-FDG PET/CT, a complete metabolical response was assessed.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bonnefoy PB, Goutte J, Jacquet-Francillon N, et al. Usual and Rare Abdominal Location of Giant Cell Arteritis Diagnosed and Follow-up With 18F-FDG PET/CT. Clin Nucl Med. 2021. PMID: 33234925. doi:10.1097/RLU.0000000000003415

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。